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This review provides an up to date information about the diverse pharmaceutical activities of
formazans. The bibliography includes 97 references which have been published during the per-
iod from 1980 to 2013. The covered biological activities of the title compounds include antioxi-
dant, anticonvulsant, therapeutic, anthelmintic, anti-tubercular, antiviral, anti-inﬂammatory,
anticancer, anti-HIV, antimicrobial, antiparkinsonian, cardiovascular and antiproliferative
activities.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Cairo University.
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Formazans, of the general formula 1 (Chart 1), are an impor-
tant and distinct class of organic compounds. Their chemistry
has attracted the interest of many research groups due to their
wide biological and industrial applications as well as their util-
ity in analytical chemistry and synthesis of heterocyclic com-
pounds. At present, there are several review articles and
books devoted to the synthesis, physical properties and chemi-
cal reactions of formazans [1–16].R-N=N-C(R’)=NNHR"                       
1 
Ar-N=N-C(Cl)=NNHAr,          R-C(X)=NNHAr,  X = Cl or Br 
2                                             3 
Ar-N=N-C(R')=N-R 
4 
Chart 1In contrast to these comprehensive literature reports on the
chemistry of formazans, there has been no survey of their bio-
logical activities hitherto although they have been found to
possess wide spectrum of biological activities such as antiviral,
antimicrobial, anti-inﬂammatory, antifungal, anticancer, anti
HIV. Based on these ﬁndings and in continuation of our stud-
ies of the chemistry of both 3-chloro-1, 5-diarylformazans 2
[17–21] and the related hydrazonoyl halides 3 [22–35]
(Chart 1), it was thought necessary to present this review.
Our objective is to shed light on the recent developments in
biological activities of various functionalized formazans 1
(Chart 1). Only recent reports that have been published during
the period from 1980 to 2013 are covered. Compounds of type
4 (Chart 1), which were erroneously named, in some articles
[36–40] as formazans, will not be included in this review as they
are amidrazone derivatives and not formazans.
At present there are three synthetic strategies for the syn-
thesis of formazans (Scheme 1) [2,3]. The ﬁrst one involves
coupling of aldehyde hydrazones with diazonium salts (Eq.
(1)). This strategy has the advantage of being able to synthesize
symmetrical and asymmetrical formazans. The second strategy
depends on coupling of active methylene compounds each with
two molar equivalents of diazonium salts (Eq. (2)). This
method proved useful for the synthesis of only symmetrical
formazans. The third method involves oxidation of the
corresponding hydrazidines (Eq. (3)) are usually prepared via
reaction of hydrazonoyl halides with the appropriate hydra-
zine derivatives. Most of the formazans, whose biological
activities are covered in this review, were prepared by the ﬁrst
method.
The general structural formulas of the various formazans
covered in this review together with their biological activities
are indicated in Table 1.
Pharmacological activities
A survey of literature reveals that many formazans have been
reported to possess wide spectrum of biological activities. In
the following, a complete coverage of the recently reported
pharmacological applications of various formazan derivatives
Table 1 The general structural formulas of the various formazans covered in this review together with their biological activities which
have been evaluated.
No. General structure Their screened biological activities
I ArAC(‚NNHAr0)AN‚NAAr00 Anti-oxidant, anticonvulsant, antiviral. anti-inﬂammatory Antimicrobial,
antiparkinsonian, analgesic
II ArAC(‚NNHAr0)AN‚NAHet Anticonvulsant, antiviral. antimicrobial, antiparkinsonian, antiproliferative
III HetAC(‚NNHAr0)AN‚NAAr00 Antiviral
IV ArAC(‚NNHACOAAr0)AN‚NAAr00 Anthelmintic, anti-inﬂammatory, anticancer, anti-HIV, antimicrobial, analgesic
V ArAC(‚NNHACOAHet)AN‚NAAr00 Anti-oxidant, Antitubercular, Antimicrobial
VI HetAC(‚NNHACOAAr0)AN‚NAAr00 Antiviral, anti-inﬂammatory
VII HetAC(‚NNHACOAAr0)AN‚NAHet0 Antimicrobial
VIII ArAC(‚NNHAR)AN‚NAAr00 Anti-inﬂammatory antimicrobial, antiparkinsonian, cardiovascular
IX ArAC(‚NNAHet)AN‚NAAr00 Antiviral, anti-inﬂammatory, antimicrobial
A review on pharmacological activities of formazans 243is presented. In such a coverage, the formazans, that have been
screened for some biological activities and found to be inac-
tive, are also pointed out.
Markers of cell vitality and antioxidant activity
Formazans are colored compounds because of the p–p* and n–
p* electronic transitions of the azo-hydrazone chromophore.
Oxidation of such compounds results in their conversion into
colorless tetrazolium salts 5 (Scheme 2) [41]. Among the vari-
ous oxidants used for the oxidation of formazans 1 to the
tetrazolium salts 5 are mercuric oxide, nitric acid, isoamyl
nitrite, N-bromo succinimide, potassium permanganate, lead
tetraacetate and t-butyl hypochlorite. When a tetrazolium salt
is given to a living organism, it is reduced back to the
corresponding colored formazan by the reductase enzyme in
the living cells and stains tissues depending upon the viability
of the organism. Accordingly, tetrazolium–formazan systems
are classiﬁed as markers of vitality [42,43].N
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Chart 2Formazans are used for screening of anticancer drugs,
determination of activity of tumor cell and sperm viability
[42–47]. They are also used in Brucella-ring test in milk [48]
and to investigate dehydrogenase activity inhibition of a soil
bacterium caused by soil contaminated with Cu, Pb and As
[49].
At present, the reduction of tetrazolium salts to formazans
is widely exploited as indicator of reducing systems with appli-
cations in chemistry and biology [36,50]. For example, it is
applied to natural products drug discovery for Leishmania
[51], the assay of lactate dehydrogenase [52] and as indicator
of viability in respiring bacteria [53]. Also, they have been used
in developing method of yeast cells permeabilization in succi-
nate dehydrogenase activity assay in situ which can be used
for different industrial Saccharomyces cerevisiae strains [54].Recently, a rapid method was reported for detection of
reduction of 2-hydroxy ketones. This method is based on
enzymatic reduction of colorless 2,3,5-triphenyltetrazolium
chloride to a red colored 1,3,5-triphenylformazan via x-
transaminases [55]. The enzymatic reductive amination of a
wide range of various aliphatic, aliphatic–aromatic and aro-
matic–aromatic 2-hydroxy ketones was determined spec-
trophotometrically at k 510 nm by the decrease in the red
coloration due to substrate consumption.
Also, the evaluation of the antioxidant effect of formazans
6a–j (Chart 2) was recently reported [56]. In that study, the for-
mazans, as antioxidants, each reacts with the stable free radical
2,2-diphenyl-1-picrylhydrazyl (DPPH) and converts it to 2,2-
diphenyl-1-picrylhydrazine. The degree of decoloration indi-
cates the scavenging potential of the compound. The results
showed that compound 6g, while it shows good activity com-
parable with the standard compound namely ascorbic acid,
the other compounds exhibited moderate to good activities.Anticonvulsant activity
Several formazans were reported to show promising anticon-
vulsant and therapeutic activities [57,58]. For example,
Mariappan et al. [58] reported the results of screening of the
formazan derivatives 7a–d and 8 (Chart 3a) for their anticon-
vulsant activity by maximum electroshock induced seizures
(MES) method using diazepam, as a standard. Compound 8
was the most active among the studied compounds. The other
compounds 7a–d were found to be moderate or less active.
None of the studied compounds showed neurotoxicity [58].
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aminopyridine displayed profound anticonvulsant activity.
Very recently, Kumara Prasad et al. [59] reported the syn-
thesis of two series of formazans 9A and 9B (Chart 4a) derived
from gallic acid and screened them for their anticonvulsant
activity by maximum electroshock method (MES). The
reported results indicate that compounds 9Ab and 9Ad exhib-
ited 55.04% and 58.73% protection as compared with the
standard phenytoin. The other compounds were found less
active.N N
H
N N
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X : a, H; b, 2-MeO; c, 3-MeO; d, 4-MeO; e, 2-NO2;
f, 3-NO2; g, 4-NO2; h, 2-Cl; i, 3-Cl; j, 4-Cl; k, 2-Me; l, 3-Me;
m, 4-Me; n, 2,4-Cl 2; o, 2,5-Cl2; p, 2,6-Cl2; q, 2-HO; r, 4-HO
 Anthelmintic activity
Nadendla et al. [60] prepared a series of formazans of type 10
(Chart 5) and screened their anthelmintic activity using the
earthworms Pheretima posthuma and albendazole. Piperazine
citrate was used as reference standard. The results of such
screening revealed that compounds 10a–d possess signiﬁcant
anthelmintic activity. The other compounds exhibited moder-
ate activity.N
O
N Me
Ar
N N
H
N
R
O
Ar'
Ar / Ar' : a, 4-O2NPh / 2-F,4-ClPh; b, 4-Me2 NPh / 4-ClPh; c, 4-Me2NPh / 2-F,4-ClPh; 
d, 2-HO,4-MePh / 2-F,4-ClPh; e, Ph / 4-BrPh; f, 4-ClPh / 4-O2NPh;
g, 4-ClPh / 4-EtPh; h, 4-O2NPh / 4-ClPh; i, 4-O2NPh / 4-BrPh; 
j, 2-HO,4-MeOPh / 4-ClPh; k, 2-pyrro lyl / 4-ClPh; l, 2-pyrrolyl / 4-BrPh;
10
R = 
N
Chart 5
Chart 7
N
N
N
H
N
C6H5
HOOC
MeO
MeO
NO2
12
Chart 8In a recent paper, Babu and Nadendla [36] reported the
synthesis of two other series of formazans namely 10A, B
(Chart 6a) and testing their anthelmintic activity on earth
worms using piperazine citrate as standard drug. The reportedresults revealed that compounds 10Aa, 10Ab, 10Ad and 10Ae
exhibited equipotent activity compared with the standard drug
while compounds 10Ac and 10Bf exhibited moderate activity.
Antitubercular activity
1-Isonicotinoyl-3-(4-methoxyphenyl)-5-(substituted phenyl)-
formazans (11a–r) (Chart 7) were tested for their in vitro
anti-tubercular activity against Mycobacterium tuberculosis
H37Rv using the BACTEC 460 radiometric system. The
results of such a study indicated that compounds 11n and
11p showed the highest antitubercular activity and exhibited
>90% inhibition at lower concentration [61].Antiviral activity
Some formazans possess antiviral activity [62,63]. For
example, 1-(o-Carboxyphenyl)-3-(30.40-dimethoxy-60-nitro-
phenyl)-5-phenylformazan 12 (Chart 8), which was prepared
by coupling of benzenediazonium chloride with the
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reported to exhibit 100% protection against the Ranikhet dis-
ease virus [62].
Misra and Dhar [63] synthesized the two formazan deriva-
tives 13 and 14 (Chart 9) by coupling of the corresponding
hydrazones each with benzene diazonium salt and screened
them for their antiviral activity against vaccinia virus and
Ranikhet disease virus in a stationary culture of chorioallan-
toic membrane of chick embryo. The results revealed that
the two compounds were found to exhibit signiﬁcant activity
87% and 83%, respectively against the Ranikhet disease virus.
However no activity against vaccinia virus could be observed
[63].AcO
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Chart 3bAlso, Mukerjee et al. [64] prepared the formazan derivatives
15a–o (Chart 10) by coupling of 3-nitro-anisaldehyde N-4-ni-
trophenylhydrazone with the appropriate aryldiazonium salts
and evaluated their antiviral activity against Ranikhet disease
virus (RDV) in chick embryos (WLH). The results of the study
of structure activity relationship (SAR) revealed that structure
variations in the aryl moiety have a high effect on their activ-
ity. For example, compound 15c with p-bromo substituent
showed 50% protection against RDV as compared with com-
pound 15a with the unsubstituted ring, whereas 4-nitro deriva-
tive 15e was found to be inactive. Also, introduction of
carboxyl group in 2- or 4-position as in formazans 15f and
15h, respectively enhances the antiviral activity where the
corresponding formazan esters 15i–l exhibit no marked antivi-
ral activity.N N
H
N
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Scheme 3Tiwari et al. [65] screened the formazan derivatives 16
(Chart 11) for their antiviral activity against Ranikhet disease
and vaccinia viruses. The results indicated that some of such
formazans showed promising activity against one or both
viruses in vitro [65].
In addition, Pandy and Negi [66] reported the synthesis of a
series of 1-(20-aryl-40-oxo(3H)quinazolyl)-3-aryl-5-phenyl-for-
mazans 17 (Chart 12) and indicated that they exhibit mild
activity against Vaccinia virus.Recently, the formazan derivatives 7 and 8 (Chart 3b) were
tested for their antiviral activity against Japanese encephalitis
virus [58]. The results showed that none of them was found
effective.Anti-inﬂammatory activity
Several formazans have been found to exhibit anti-
inﬂammatory activity [67–69]. For example, in a recent article,
Babu and Naderndia [70] reported the synthesis of two series
of formazans 10A and 10B (Scheme 3) and the results of their
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246 A.S. Shawali and N.A. Samyanti-inﬂammatory screening. The results revealed that the
compounds 10Ad, 10Ae, 10Ae and 10Bf afforded 67% protec-
tion against carrageenan induced edema equally with the stan-
dard drug diclofenac sodium under similar conditions while
compounds 10Ab, 10Ac, 10Af, 10Ag, 10Bd and 10Bg exhibited
33% protection.
The substituted quinazolonoformazans 18–20 were also
synthesized as depicted in Scheme 4 and were screened for their
anti-inﬂammatory activity [68]. The results indicated that all
compounds except 20a, possessed anti-inﬂammatory activity.
The degree of protection provided by these compounds
(100 mg/kg, po) against carrageenan-induced edema in rat
paw ranged from 26% to 57%. Such protection was com-
parable to that of 51% observed with phenylbutazone
(100 mg/kg, po) which was used as a standard reference drug.
Regarding the structure–activity relationship, the results
showed that compounds 19 possessed higher anti-in-
ﬂammatory activity than that of 20 with the exception of
20d. The authors [68], in an attempt to gain some idea of their
possible analgesic effectiveness, they screened also compounds
19a, b and 20b, d for their antiwrithmogenic activity. The
results showed that three of such compounds namely 19a, b
and 20b showed 10–50% protection against aconitine-induced
writhing response in mice, whereas compound 20d exhibited
80% protection similar to that of acetylsalicylic acid.N
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NCCH CHFurthermore, Kumar et al. [71] synthesized the formazans
21 (Chart 13) and tested them for their anti-inﬂammatory
activity in albino rats. The results indicated that they exhibit
only moderate activity.O N
N N
C6H4Y
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Chart 13
O OH
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X : a, 4-Me; b, 4-Cl; c, 4-MeO; d, 4-NO2; e, 4-HOOC  
Chart 15Formazans 22 (Chart 14) were synthesized by Kumar et al.
[72] and their anti-inﬂammatory activity was screened against
carrageenan-induced edema in albino rats. On the basis of
the results of such screening, the authors concluded that such
formazans exhibit promising anti-inﬂammatory activity.Very recently, Kumara Prasad et al. [59] reported the
results of screening of compounds 9A and 9B (Chart 4b) for
their anti-inﬂammatory activity by carrageenan induced rat
paw edema inhibition method. The reported results indicate
that compounds 9Ac and 9Bc are the most active among the
tested compounds. The other compounds were found less
active.Anticancer and anti-HIV activities
Some formazans were tested for their anticancer and anti-HIV
activities [73–75]. The results showed that most of the tested
formazans were inactive.
Bhardwaj and Jolly [76] synthesized the formazan deriva-
tives 23 (Chart 15) and evaluated them for anticancer and
ant-HIV activities. The results revealed that the studied com-
pounds did not show any signiﬁcant anticancer or anti-HIV
activity [76].In another report, Bhardwaj [77] prepared also a similar
series of formazans 24 (Chart 16) and the results of testing
them for anticancer activity. The results revealed that none
of the compounds was found active at the dose level tested.
Also, the compounds did not show signiﬁcant anti-HIV
activity.
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Chart 19a
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for anticancer and anti-HIV activities [78]. However, none of
such compounds was found active at the dose level tested.N
NCCH2CH2
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X : a, H; b, 2-Me; c, 3-Me; d,  4-Me; e, 2-Cl; f, 3-Cl; 4-Cl;
g, 2-COOH; h, 4-COOH; i, 2-MeO; j, 3-MeO; k, 4-MeO; 
l, 2-O2N; m, 3-O2N; n, 4-O2N 
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Chart 17Furthermore, the formazans 26a–o (Chart 18) were pre-
pared and screened for their anti-cancer and anti-HIV activi-
ties [79]. The results of such a study revealed that the
compounds 26b, d, e, f, i, j, k, l, o did not show any signiﬁcant
anticancer activity or anti-HIV activity.N N
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C6H4X
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l, 3-NO2; m, 4-NO2; n, 2-HOOC; o, 3-HOOC
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Chart 20Antimicrobial activities (Antibacterial and antifungal activities)
Several formazan derivatives have shown a broad spectrum of
activity against pathogens [49,69,73,80,81]. Raval et al. [82]
synthesized the formazans 27a–m (Chart 19a) and screened
them for their antibacterial activity against representative
Gram-positive organisms viz. Bacillus subtilis (MTCC 121),
Micrococcus luteus (MTCC 106), Bacillus sphaericus
(MTCC 11) Staphylococcus aureus (MTCC 96) and Gram-
negative organisms viz. Chromobacterium violaceum (MTCC
2656), Klebsiella aerogenes (MTCC 39), Pseudomonasaeruginosa (NTCC 791), Escherichia coli (MTCC 443),
Klebsiella pneumoniae (MTCC 109), Salmonella paratyphi
A(MTCC 735) using standard antibacterial agents like peni-
cillin and streptomycin under identical conditions for compar-
ison [82]. The results showed that the tested compounds 27a, d,
h, k possessed the highest degree of inhibition against all tested
Gram + ve organisms, while compounds 27c and 27h showed
highest degree of inhibition against all tested Gram –ve organ-
isms. Compounds 27c, d, h, k showed highest degree of inhibi-
tion against Escherichia coli, Klebsiella pneumoniae, Salmonella
paratyphi A, while compound 27k showed highest inhibition
against Chromobacterium violaceum, Klebsiella aerogenes,
Pseudomonas aeruginosa, Escherichia coli respectively [82].
Lakshmi et al. [83] prepared the formazans 28a–i (Chart 20)
and evaluated their antimicrobial activity by the cup–plate
agar diffusion method. All the synthesized compounds were
tested in vitro for their antibacterial activity against various
microbes such as Bacillus subtilis NCIM 2063, Escherichia coli
NCIM 2118, Pseudomonas aeruginosa NCIM 2036 and
antifungal activity against Candida albicans NCIM 3102.
Ciproﬂoxacin (10 lg/disk) and Fluconazole (2 lg/disk) were
used as standard. The results showed that compounds 28a, c,
g, h, i were active against Bacillus subtilis and 28b, d, e, h, i
showed signiﬁcant activity against Escherichia coli.
Compounds 28a, c, d, e, g, h, i showed activity against
Pseudomonas aeruginosa. The compounds 28a, b, c, f, g, h, i
were found active against Candida albicans. The other com-
pounds were resistant to the selected microbial strains [83].In another report Revanasiddappa and Subrahmanyam
[84] synthesized the formazans 29a–l (Chart 21) by coupling
the corresponding hydrazones with the appropriate diazonium
salts and assayed them in vitro for antibacterial activity against
S. aureus, P. aeruginosa, E. coli and B. subtilis and antifungal
activity against C. albicans and A. ringer by the cup–plate
method using DMF as solvent. The activity was compared
N N
H
N
C6H4X
O
NR
29
R / X : a, H / H; b, H / 4-Me; c, H / 4-Cl; d, H /4-(pyrimidin-2-yl-NHSO2);
e, 4-Me / H; f, 4-Me / 4-Me; g, 4-Me / 4-Cl; 
h, 4-Me / 4-(pyrimidin-2-yl-NHSO2); i, 4-Cl / H; j, 4-Cl / 4-Me;
k, 4-Cl / 4-Cl; l, 4-Cl / 4-(pyrimidin-2-yl-NHSO2)
N
Chart 21
XC6H4
N N
H
Ar'
Het
N
N
H
O
O
Me
30-32
X : 30, 4-MeO; 31,  4-Br; 32, 4-Cl
Ar' = YC6H4 : Y : a, H,; b, 2-Me; c, 2-MeO; d, 3-MeO; e, 4-MeO;
f, 4-Cl; g, 3-Cl; h, 4-F; i, 3-F; j, 4-t-Bu
Het =
N N
Chart 22
N
N N
H
N
XC6H4
SO2R
248 A.S. Shawali and N.A. Samywith the known antibiotics namely Streptomycin and
Griseofulvin under the same conditions. The results of the anti-
bacterial studies indicated that the compounds 29b, e, g, i pos-
sess good activity against both the Gram positive and gram
negative pathogenic organisms [84]. The rest of the compounds
showed moderate activity against all the four organisms. In the
antifungal activity, the compounds 29b and 29h showed high-
est activity against both the fungal organisms. The other com-
pounds showed moderate activity [84].
Recently, Mariappan et al. [58] screened the formazan
derivatives 7a–d and 8 (Chart 3c) for antibacterial activity.
All the compounds were reported to show remarkable antibac-
terial activity against Gram positive organism S. aureus except
7d. From the SAR point of view, it is interesting to observe
that the formazan derived from hetero aniline 8 displayed pro-
found antibacterial activities. The order of activity of
8> 7c> 7a> 7b. Also, all the compounds showed remark-
able antibacterial against Gram negative bacteria Vibrio cho-
lerae. However, the antibacterial activity of the studied
compounds was lower than that of streptomycin at 250 lg/
ml [58].N N
H
N N
C6H4X
Ph
Ph
N N
H
N N
Ph
Ph
N
7 8
X : a, 4-NO2; b, 4-Cl; c, 2,3-Cl2; d, 3-Cl
Chart 3c
Ph33-35
R : 33, Et2N; 34, Ph-N(CH2CH2)2N; 35, 3-ClC6H4-N(CH2CH2)2N
X : a, H; b, 4-Me; c, 4-MeO; d, 4-HO
Chart 23
N N
H
O
N
MeO
N N
Ar
36
Ar =  XnC6H5-n
X : a, H; b, 2-MeO; c, 3-MeO; d, 4-MeO; e, 2-NO2; f, 3-NO2; g, 4-NO2;
h, 2-Cl; i, 3-Cl; j, 4-Cl; k, 2- Me; l, 3-Me; m, 4-Me; n, 2,4-Cl2;
o, 2,5-Cl2; p-2,6-Cl2; q, 2-HO; r, 4-HO
Chart 24Three other series of uracil formazans 30–32 (Chart 22)
were synthesized by coupling of the corresponding hydrazone
derivatives with diazonium salts of various substituted aro-
matic amines and were screened for their antimicrobial activi-
ties against E. coli and S. Aureus and antifungal activity
against S. Cerevisiae and C. albicans at a concentration of
60 lg/mL in DMF by cup–plate method [75]. Standard anti-
bacterial and anti-fungal drug, gentamycin and miconazole,
respectively were also used under similar conditions for com-
parison. The results revealed that compounds 30c and 31g
are good antibacterial agents against E. coli whereas com-
pounds 31b, 32a and 32b exhibit better activity against S.
aureus.The formazans 33–35 (Chart 23) have been prepared by
Vashi and Sheth [85] and were screened for antimicrobial
activity against Gram positive (B. subtilis and S. aureus) and
Gram negative (E. coli and P. aeruginosa) organisms using
DMF as solvent at 50 mg/mL concentration at 37 C. The
activity was compared with the standard drugs viz, ampicillin,
tetracycline, gentamycin and chloramphenicol. The results of
such screening revealed that compounds 34a–d, 35a–c, 34a–d
and 35b–d exhibited good activity against the tested Gram
negative and Gram positive bacteria, whereas compounds
33a–d showed moderate to mild activity against all four bac-
teria as compared to standard drugs.Raval et al. [82] reported the synthesis of a series of 3-(4-
methoxyphenyl)-1-isonicotinoyl-5-(substituted phenyl)for-
mazans (36a–r) (Chart 24) and their antimyco-bacterial activ-
ity in vitro against M. tuberculosis H37Rv using the BACTEC
Ar
N N
H
Ar'
O N
N
O
Me38
Ar / Ar' : a, Ph / 4-ClPh; b, Ph / 4-BrPh; c, 4-ClPh / 4-O2NPh;  
d, 4-ClPh / 4-EtPh; e, 4-O 2NPh / 4-ClPh; f, 4-O2NPh / 4-BrPh;
g, 4-O2NPh / 3-F,4-ClPh; h, 4-Me2NPh / 4-ClPh;
i, 4-Me2NPh / 3-F,4-ClPh; j, 2-HO,4-MeOPh / 4-ClPh;
k, 2-HO,4-MeOPh / 3-F,4-ClPh; l, 2-pyridyl / 4-ClPh;
m, 2-pyridyl / 4-BrPh
N N
Chart 25
Ar
N N
H
N
S
N
N
Ar'
Cl
39
Ar = XC6H4 Ar' = YC6H4
X / Y : a, H / H; b, H / 4-Cl; c, H / 4-F; d, H / 4-Me; e, H / 4-Br;
f, 2-HO / H; g, 2-HO / 4-F; h,  2-HO / 4-Cl; i, 4-MeO / 4-Me;
j, 4-MeO / 4-Cl; k, 4-MeO / H; l, 4-MeO / 4-F; m, 2-NO 2 / 4-F;
n, 2-NO2 / 4-Cl; o, 2-NO2 / 4-Me
Chart 26
A review on pharmacological activities of formazans 249460 radiometric system. The results showed that 3-(4-methox-
yphenyl)-5-(2,4-dichlorophenyl)-1-isonicotinoylformazan (36n)
and 3-(4-methoxyphenyl)-5-(2,6-dichlorophenyl)-1-isonicoti-
noyl-formazan (36p) produced highest efﬁcacy and exhibited
>90% inhibition at a concentration of 0.0179 lM and
0.0149 lM whereas 3-(4-methoxyphenyl)-5-(2-methoxyphe-
nyl)-1-isonicotinoylformazan (36b), 3-(4-methoxyphenyl)-5-
(4-methoxyphenyl)-1-isonicotinoylformazan (36d) and 3-(4-
methoxyphenyl)-5-(2,5-dichlorophenyl)-1-isonicotinoylfor-
mazan (36o) showed moderate inhibitory activity with
0.0277 lM, 0.0203 lM, 0.0292 lM respectively. This ﬁnding
was taken as evidence that the 2,4-dichloro and 2,6-dichloro
groups substitution derivatives displayed relatively higher inhi-
bitory activity in general. However, the electron rich groups
such as, 2,4-dichloro, 2,5-dichloro, 2,6-dichloro, 2-methoxy,
3-methoxy and 4-methoxy substituted analogs produced sig-
niﬁcant increase in inhibitory activity against M. tuberculosis
H37Rv [82]. On the other hand, analogs with methyl group
substitution (36k–m) and phenyl substitution (36a) were
reported to show relatively low inhibitory activity against M.
tuberculosis H37Rv. Instead (OH) group, (CH3) group and
(NO2) group substitution at phenyl ring in formazan analogs
worsens the anti-mycobacterial activity in comparison with
(Cl) group analogs.
In another report, Raval et al. [61] indicated that the results
of screening the antimicrobial activities of formazans 37a–m
(Chart 19b) revealed that compounds 37a, d, h and 37k exhib-
ited the highest degree of inhibition against all tested Gram
+ve organisms, while compounds 37c, h showed highest
degree of inhibition against all tested Gram ve organisms
compared to standard antibiotic drugs. Compounds 37c, d, h
and 37k showed highest degree of inhibition against
Escherichia coli, Klebsiella pneumoniae, Salmonella paratyphi
A, while compound 37k showed highest inhibition against
Chromobacterium violaceum, Klebsiella aerogenes,
Pseudomonas aeruginosa, Escherichia coli, respectively [61].N N
H
O
N
MeO
N N
Ar
37
Ar =  XC6H5
X : a, H; b, 2-MeO; c, 3-MeO; d, 4-MeO; e, 2-NO2; f, 3-NO2; g, 4-NO2;
h, 2-Cl; i, 3-Cl; j, 4-Cl; k, 2-Me; l, 3-Me; m, 4-Me
Chart 19bNadendla et al. [60] synthesized a series of quinazolinone
formazans 38a–m (Chart 25) and screened them for antibacter-
ial activity against six bacterial strains namely Bacillus subtilis,
Bacillus cereus, Escherichia coli, Staphylococcus aureus,
Staphylococcus epidermidis, Pseudomonas aeruginosa and
antifungal activity against four fungal strains: Candida albi-
cans, Candida glabrata, Aspergillus niger and Saccharomyces
cerevisiae by paper diffusion method. Of the compounds stud-
ied only compounds 38f, g, h and 38k showed moderate to
good inhibition.
Various (6-chloro-benzothiazol-2-yl)formazans 39
(Chart 26) were synthesized by Basavaraja et al. [86] andevaluated for their antimicrobial activity against E. coli,
Pseudomonas, Staphylococcus aureus, Bacillus subtilis and
antifungal activity against Aspergillus. Flavus and Candida albi-
cans using DMF as solvent at 50 and 100 lg/ml concentration
by using cup–plate method. The activities were compared with
known reference drugs like procaine penicillin, Streptomycin
and Griseofulvin [86]. The results showed that compounds
39l–n are active against S. aerus whereas compounds 39h, j
are active against B. subtilis. In addition, while the formazans
39j, n, m exhibited activities against E. coli and Pseudo Mona
comparable to that of the standards used. Furthermore, com-
pounds 39c, h, l and 39d, n possessed activities close to that of
Griseofulvin against Candida albicans and Aspergillus Flavus,
respectively [86].
Recently, Uraz et al. [80] reported the synthesis of the for-
mazans 40–42 (Chart 27) with various substituents on 1,3,5-
sites and their antimicrobial activity against some selected
microorganism namely, Staphylococcus aureus, S. epidermidis,
S. saprophyticus, Pseudomonas aeruginosa, Escherichia coli,
Klebsiella pneumoniae. Moreover, the antifungal effects of
these formazans were tested on the Candida keﬁr, C. glabrata,
C. tropicalis, Cryptococcus neofarmans, and Saccharomyces
cerevisiae. The results of that study indicated that the studied
formazans were very active against Candida keﬁr, C. tropicalis,
Cryptococcus neofarmans and Saccharomyces cerevisiae [80].
N N
H
N N
Ph
Ph
Ph
N N
H
N N
Ar
Ar
N
N
N N
H
N N
Ar
C6H4X
N
40 41
Ar = 4-MeOC6H4
42
Ar / X : a, p-anisyl / 4-MeO; b, 2-HOC6H4 / 3-Me;
c, 3-HOC6H4 / 3-Me; d, 4-HOC6H4 / 3-Me;
e, 2-Phenanthrenyl / 4-MeO
Chart 27
XC6H4
N N
H
C6H4R
N45
R : 4-MeO; 2-Cl
X : 2-MeO; 4-MeO; 4-EtO; 4-HO; 3-HO
N N
Chart 30
250 A.S. Shawali and N.A. SamyFurthermore, Sah et al. [87] reported the synthesis of the
formazans 43a–g (Chart 28) containing 1,3,4-thiadiazole ring
residue and their in vitro antibacterial activity against
Escherichia coli and Salmonella typhi and antifungal activity
against Aspergillus sp. and Candida albicans. The results
revealed that all of the studied compounds showed moderate
activities.Ar
N N
H
Ar'
O O
N
S
N
N
H
Cl
S
O2N
O2N
43
Ar / Ar' : a, 2-ClPh / 4-O2NPh; b, 2-ClPh / 2-Me,4-NO2C6H3;
c, 2-ClPh / 4-HO3SC6H4; d, 2-ClPh / 4-H2NSO2C6H4;
e, 2-ClPh / 4-H2NC(=NH)NH-SO2C6H4; 
f, 3-MeO,4-HOC6H3 / 2-pyrimidinyl-SO2C6H4;
g, 3-MeO,4-HOC6H3 / 4,6-Me2-pyrimidin-2-yl-SO2C6H4
N N
Chart 28
N N
H
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S
C6H4NO2-p
S
N
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Chart 31
Other formazans 44a–e (Chart 29) were synthesized by
Desai et al. [88] and were assayed for their in vitro antibacterial
activity against E. coli, P. ﬂuorescence, B. mega, B. subtilis, and
antifungal activity against Aspergillus awamori using DMF as
solvent at 50 lg concentration by cup–plate method. The activ-
ity was compared with the known antibiotic namely ampicillin,
chloramphenicol, norﬂoxacin, and griseofulvin at the same
concentration. The results showed that compounds 44b–d
exhibit antibacterial activity similar to that of ampicillin andN
H
N
XC6H4
O
SO2NH2
NO2
44
X : a, H; b, 4-Cl; c, 4-EtO; d, 4-MeO; e, 2-NO2
N N
Chart 29compound 44e showed comparable antifungal activity as that
of griseofulvin.
Also, Tandel et al. [89] reported the synthesis of formazans
45 (Chart 30) and indicated that they exhibited potent activity
against E. coli, B. Subtilis, S. aureus, and S. paratyphi B
bacteria.The formazans 46a–j (Chart 31) have been prepared by
Desai et al. [90] and screened them for antifungal activity
against Candida albicans, Candida krusei, and Candida parap-
silosis and antibacterial activity against Escherichia coli,
Staphylococcus aureus, Pseudomonas aeruginosa and Bacillus
subtilis.Very recently, the synthesis of the formazans 47a–j
(Chart 32) and the results of screening of their antibacterial
and antifungal activities were reported by Bhosale et al. [56].
The results indicated that all compounds 47a–j showed good
activities against all strains of bacteria. For example, com-
pound 47i showed excellent activities against the species
Pseudomonas aeruginosa, Klebsiella pneumonia and Bacillus
subtilis comparable with the standard antibacterial agentN N
H
NN
O
R
N
H
Me
Me
Ph
47
R : a, Ph; b, 4-MeOC6H4; c, 2-ClC6H4; d, 4-Me2NC6H4; e, 2-furyl;
f, PhCH2CH2-; g, 4-HOC6H4; h, 3,4-(MeO)2C6H3; 
i, 2-HOC6H4; j, 3,4-CH2O2C6H3
Chart 32
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H
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C6H4X
O
N
N
O
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O2N
10A
X : a, H; b, 4-Cl; c, 3-Cl; d, 4-Br; e, 4-NO2; f, 3-F,4-Cl;
g, 4-Et; h, 4-Me
Chart 6b
A review on pharmacological activities of formazans 251tetracycline. Compound 47g showed good activity among all
the compounds studied against Salmonella typhi. In antifungal
assay, while compounds 47a–i demonstrated moderate results
against the fungi Aspergillus niger, compounds 47a–j displayed
good antifungal activities against Aspergillus ﬂavus.
Also, Rajput [91] synthesized a series of 1-isonicotinoyl-3-
(4-methoxyphenyl)-5-substituted phenyl)formazans 48a–n
(Chart 19c) and screened them for their antimicrobial activity
against Escherichia coli, Bacillus, Salmonella typhimurium and
A niger using DMF as solvent and nutrient agar was employed
as culture media. The results showed that the studied com-
pounds were only active against E. coli.N N
H
NN
O
C6H4X
MeO
N
48
X : a, H; b, 2-Cl; c, 3-Cl; d, 4-Cl; e, 2-NO2 ;
f, 3-NO2; g, 4-NO2; h, 2-Me; i, 4-Me; j, 2-MeO; 
k, 4-MeO; l, 4-SO3H; m, 2-COOH; n, 2-SO3H
Chart 19c
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OH
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X : a, H; b, 4-COOH; c, 4-OH; d, 4-NO2
9A 9B
Chart 4d
C5H4R'Very recently, Kumara Prasad et al. [59] reported the
results of assaying the formazan derivatives 9A(B) (Chart 4c)
for antibacterial activity against Staphylococcus aureus and
Escherichia coli and anti fungal activity against Aspergillus
Niger in comparison with oﬂoxacin and ﬂuconazole as stan-
dard. The reported results indicate that compounds with elec-
tron withdrawing substituents namely 9Ab and 9Ad are the
most active among the tested compounds. The other com-
pounds were found less active.N N
H
N N
C6H4X
O2N
O
OH
OH
OH
N N
H
N N
C6H4X
OH
O
OH
OH
OH
X : a, H; b, 4-COOH; c, 4-OH; d, 4-NO2
9A 9B
Chart 4c
RC6H4
N N
H
NN
O
N
S
R / R': a, H / 2-Me; b, H / 2,5-Cl 2; c, 3,4-(MeO)2 / 2,5-Cl2
22
Chart 33a
N N
H
NN
Ar
Ph
Ph
N N
H
NN
Ph
Ph
N
7 8
X : a, 4-NO2; b, 4-Cl; c, 2,3-Cl 2; d, 3-Cl
Ar = XnC6H5-n
Chart 3dAnalgesic activity
Nadendla and Babu [92] prepared a series of 1-substituted
phenyl-3-(4-nitrophenyl)-4-[benzamido-(2-methyl-3-quinazolin)-
4-one]formazans 10Aa–h (Chart 6b) and screened them for
analgesic activities. The reported results revealed that only com-
pounds 10d, e, f exhibit signiﬁcant analgesic activity compared
to the standard namely paracetamol.
Very recently, Kumara Prasad et al. [59] synthesized the
two series of formazan derivatives 9A, B (Chart 4d) and
screened them for their analgesic activity using Eddy’s Hot
Plate Method. The reported results indicate that compounds
9Ac and 9Bc are the most active among the tested compounds.
The other compounds were found less active.Antiparkinsonian activity
The formazans 22a–c (Chart 33a) were prepared by coupling
diazotized anilines with aldehyde N-(10-phenothiazinyl-
acetyl)hydrazones. Compounds 22a–c were reported to exhibit
prominent antiparkinsonian activity better than 1-dopa and
bromocriptine in mice/rats (in vivo) with no toxicity effects with
doses 61000 mg/kg [93,94].Very recently, Mariappan et al. [58] reported that the for-
mazan derivatives 7–8 (Chart 3d) showed signiﬁcant
p-RC6H4
N N
H
NN
C6H4X
Ph
X: a, H; b, 2-NO 2; c, 3-NO2; d, 4-NO2; e, 2-Me; f, 3-Me; g, 4-Me; 
51A(B)
R: A, H; B, MeOOC
252 A.S. Shawali and N.A. Samyanticonvulsant effect at 100 mg/kg po and the experimental
data were statistically signiﬁcant at P< 0.001 level.
Cardiovascular activity
Three 1,3-disubstituted phenyl-5[(2-acetyl-phenothiazin-10-
yl)-2-oxo-ethyl]formazans 22 (Chart 33b) have been reported
and were evaluated for their cardiovascular activity [95].Ar
N N
H
NN
Ar'
O
N
S
X / Y: a, H / 2-Me; b, H / 2,5-Cl 2; c, 3,4-(MeO)2 / 2,5-Cl2
22
Ar = XnC6H5-n
Ar' = YC6H5-n
Chart 33b
h, 2-MeO; i, 3-MeO; j, 4-MeO; k, 2-I; l, 3-I; m, 4-I
Chart 35Anti-proliferative activity
As prolactin and other lactogenic hormones are mitogenic for
the rat T-cell lymphoma line Nb2 and glucocorticoids have
antiproliferative effects on these cells, Alder et al. used the
tetrazolium salt 49 (MTT) (Chart 34) for proliferation assay
for the Nb2 cell line. Reduction of the yellow MTT to form
the corresponding purple formazan 50 increases with cellular
metabolic activity due to elevated NAD(P)H ﬂux [96].
Resting cells such as thymocytes and splenocytes that are
viable but metabolically quiet reduce very little MTT. In con-
trast, rapidly dividing cells exhibit high rates of MTT
reduction.N N
NN
S
N
Me
Me
Ph
Ph
N N
N
H
N
Ph
Ph
S
N
Me
Me
+
Br -
49, MTT 50
Chart 34Recently, Yaglıoglu and Seno¨z [97] reported the results of
antiproliferation activity of 1,3,5-triphenylformazan 51Aa
and 1-substituted phenyl-3-(4-methoxycarbonyl)-phenyl-5-
phenylformazans 51Ba–m (Chart 35) against HeLa an C6 cell
line using BrdU cell proliferation ELISA assay. Cisplatin and
5-ﬂorouracil were used as standards. The activities of the
studied compounds and standards were investigated on eight
concentrations. The results revealed that compounds with
2-OCH3, 3-CH3 and 4-I substituents displayed maximum
activity against HeLa while those having 2-NO2, 3-I and also
4-I groups were active against C6.Conclusions
This review presents an up-to-date survey of the various bio-
logical activities of formazans. The literature reports covered
in this review indicate that formazans exhibit versatile biologi-
cal activities. It is hoped that this review will capture the atten-
tion of other research groups to develop newer formazans that
could be better agents in terms of efﬁcacy and safety.
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